IN2012DN02196A - - Google Patents
Download PDFInfo
- Publication number
- IN2012DN02196A IN2012DN02196A IN2196DEN2012A IN2012DN02196A IN 2012DN02196 A IN2012DN02196 A IN 2012DN02196A IN 2196DEN2012 A IN2196DEN2012 A IN 2196DEN2012A IN 2012DN02196 A IN2012DN02196 A IN 2012DN02196A
- Authority
- IN
- India
- Prior art keywords
- treatment
- relates
- autoimmune
- inflammatory disorders
- epratuzumab
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
- A61K39/39566—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against immunoglobulins, e.g. anti-idiotypic antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Epidemiology (AREA)
- Rheumatology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Cardiology (AREA)
- Transplantation (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Pain & Pain Management (AREA)
- Heart & Thoracic Surgery (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US24379709P | 2009-09-18 | 2009-09-18 | |
| PCT/EP2010/005225 WO2011032633A1 (en) | 2009-09-18 | 2010-08-26 | Treatment of autoimmune and inflammatory diseases with epratuzumab |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2012DN02196A true IN2012DN02196A (de) | 2015-08-21 |
Family
ID=43063209
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN2196DEN2012 IN2012DN02196A (de) | 2009-09-18 | 2010-08-26 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20110070227A1 (de) |
| EP (1) | EP2478012B1 (de) |
| JP (1) | JP5816905B2 (de) |
| KR (1) | KR20120100914A (de) |
| CN (1) | CN102574920A (de) |
| AU (1) | AU2010294905B2 (de) |
| BR (1) | BR112012006035A2 (de) |
| CA (1) | CA2774244A1 (de) |
| EA (1) | EA026902B1 (de) |
| ES (1) | ES2608661T3 (de) |
| IN (1) | IN2012DN02196A (de) |
| MX (1) | MX341117B (de) |
| WO (1) | WO2011032633A1 (de) |
Families Citing this family (41)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2006138181A2 (en) | 2005-06-14 | 2006-12-28 | Amgen Inc. | Self-buffering protein formulations |
| MX342994B (es) | 2008-05-23 | 2016-10-21 | Siwa Corp | Métodos, composiciones y aparato para facilitar la regeneración. |
| CA2807552A1 (en) | 2010-08-06 | 2012-02-09 | Moderna Therapeutics, Inc. | Engineered nucleic acids and methods of use thereof |
| CN104531671A (zh) | 2010-10-01 | 2015-04-22 | 现代治疗公司 | 设计核酸及其使用方法 |
| EP2691101A2 (de) | 2011-03-31 | 2014-02-05 | Moderna Therapeutics, Inc. | Freisetzung und formulierung von manipulierten nukleinsäuren |
| US9464124B2 (en) | 2011-09-12 | 2016-10-11 | Moderna Therapeutics, Inc. | Engineered nucleic acids and methods of use thereof |
| EP3492109B1 (de) | 2011-10-03 | 2020-03-04 | ModernaTX, Inc. | Modifizierte nukleoside, nukleotide und nukleinsäuren und verwendungen davon |
| US9757458B2 (en) * | 2011-12-05 | 2017-09-12 | Immunomedics, Inc. | Crosslinking of CD22 by epratuzumab triggers BCR signaling and caspase-dependent apoptosis in hematopoietic cancer cells |
| WO2013090648A1 (en) | 2011-12-16 | 2013-06-20 | modeRNA Therapeutics | Modified nucleoside, nucleotide, and nucleic acid compositions |
| US8999380B2 (en) | 2012-04-02 | 2015-04-07 | Moderna Therapeutics, Inc. | Modified polynucleotides for the production of biologics and proteins associated with human disease |
| US9878056B2 (en) | 2012-04-02 | 2018-01-30 | Modernatx, Inc. | Modified polynucleotides for the production of cosmetic proteins and peptides |
| US9283287B2 (en) | 2012-04-02 | 2016-03-15 | Moderna Therapeutics, Inc. | Modified polynucleotides for the production of nuclear proteins |
| US9572897B2 (en) | 2012-04-02 | 2017-02-21 | Modernatx, Inc. | Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins |
| MX364327B (es) | 2012-10-12 | 2019-04-23 | Medimmune Ltd | Conjugados del anticuerpo pirrolobenzodiazepina - anti-cd22. |
| US9597380B2 (en) | 2012-11-26 | 2017-03-21 | Modernatx, Inc. | Terminally modified RNA |
| US8980864B2 (en) | 2013-03-15 | 2015-03-17 | Moderna Therapeutics, Inc. | Compositions and methods of altering cholesterol levels |
| EP3052106A4 (de) | 2013-09-30 | 2017-07-19 | ModernaTX, Inc. | Polynukleotide zur codierung immunmodulierender polypeptide |
| BR112016007255A2 (pt) | 2013-10-03 | 2017-09-12 | Moderna Therapeutics Inc | polinucleotídeos que codificam receptor de lipoproteína de baixa densidade |
| WO2015052535A1 (en) | 2013-10-11 | 2015-04-16 | Spirogen Sàrl | Pyrrolobenzodiazepine-antibody conjugates |
| EP3954703A3 (de) | 2014-05-29 | 2022-05-18 | MacroGenics, Inc. | Trispezifische bindemoleküle und verfahren zur verwendung davon |
| MX2017003565A (es) * | 2014-09-19 | 2017-07-14 | Siwa Corp | Anticuerpos anti-edad para el tratamiento de inflamacion y trastornos autoinmunes. |
| US9993535B2 (en) | 2014-12-18 | 2018-06-12 | Siwa Corporation | Method and composition for treating sarcopenia |
| US10358502B2 (en) | 2014-12-18 | 2019-07-23 | Siwa Corporation | Product and method for treating sarcopenia |
| GB201506402D0 (en) | 2015-04-15 | 2015-05-27 | Berkel Patricius H C Van And Howard Philip W | Site-specific antibody-drug conjugates |
| GB201506411D0 (en) | 2015-04-15 | 2015-05-27 | Bergenbio As | Humanized anti-axl antibodies |
| EP3337829B1 (de) | 2016-02-19 | 2020-01-08 | Siwa Corporation | Verfahren und zusammensetzung zur behandlung von krebs, abtötung von metastasierenden krebszellen und verhinderung von krebsmetastasen mit einem antikörper gegen fortgeschrittene glykierungsendprodukte |
| CA3057829A1 (en) | 2016-04-15 | 2017-10-19 | Siwa Corporation | Anti-age antibodies for treating neurodegenerative disorders |
| JP2019518763A (ja) | 2016-06-23 | 2019-07-04 | シワ コーポレーション | 様々な疾患及び障害の治療において使用するためのワクチン |
| GB201617466D0 (en) | 2016-10-14 | 2016-11-30 | Medimmune Ltd | Pyrrolobenzodiazepine conjugates |
| CN114917185B (zh) | 2016-10-21 | 2023-11-14 | 美国安进公司 | 药物配制品及其制备方法 |
| GB201702031D0 (en) | 2017-02-08 | 2017-03-22 | Medlmmune Ltd | Pyrrolobenzodiazepine-antibody conjugates |
| SI3544636T1 (sl) | 2017-02-08 | 2021-08-31 | Adc Therapeutics Sa | Konjugati pirolobenzodiazepin-protitelo |
| US10919957B2 (en) | 2017-04-13 | 2021-02-16 | Siwa Corporation | Humanized monoclonal advanced glycation end-product antibody |
| DK3612537T3 (da) | 2017-04-18 | 2022-08-08 | Medimmune Ltd | Pyrrolobenzodiazepinkonjugater |
| CN110536703B (zh) | 2017-04-20 | 2024-07-12 | Adc治疗有限公司 | 使用抗axl抗体-药物缀合物的组合疗法 |
| CA3064804A1 (en) | 2017-06-14 | 2018-12-20 | Adc Therapeutics Sa | Dosage regimes for the administration of an anti-cd19 adc |
| SI3668874T1 (sl) | 2017-08-18 | 2022-04-29 | Medimmune Limited | Pirolobenzodiazepinski konjugati |
| US11518801B1 (en) | 2017-12-22 | 2022-12-06 | Siwa Corporation | Methods and compositions for treating diabetes and diabetic complications |
| GB201803342D0 (en) | 2018-03-01 | 2018-04-18 | Medimmune Ltd | Methods |
| GB201806022D0 (en) | 2018-04-12 | 2018-05-30 | Medimmune Ltd | Pyrrolobenzodiazepines and conjugates thereof |
| EP3867280A4 (de) * | 2018-10-18 | 2022-11-09 | Sinomab Bioscience Limited | Verfahren zur behandlung von rheumatoider arthritis |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5179017A (en) * | 1980-02-25 | 1993-01-12 | The Trustees Of Columbia University In The City Of New York | Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials |
| GB8308235D0 (en) * | 1983-03-25 | 1983-05-05 | Celltech Ltd | Polypeptides |
| US5484892A (en) * | 1993-05-21 | 1996-01-16 | Dana-Farber Cancer Institute, Inc. | Monoclonal antibodies that block ligand binding to the CD22 receptor in mature B cells |
| WO1996004925A1 (en) * | 1994-08-12 | 1996-02-22 | Immunomedics, Inc. | Immunoconjugates and humanized antibodies specific for b-cell lymphoma and leukemia cells |
| KR20020020730A (ko) * | 1999-06-09 | 2002-03-15 | 오트리브 데이비스 더블유 | Ｂ-세포를 표적하는 항체를 이용한 자가면역질환의 면역치료 |
| DK3284753T3 (da) * | 2002-10-17 | 2021-07-05 | Genmab As | Humane monoklonale antistoffer mod cd20 til anvendelse i behandlingen af multipel sclerose |
| EP2650306A1 (de) * | 2006-03-06 | 2013-10-16 | Aeres Biomedical Limited | Humanisierte Anti-CD22-Antikörper und ihre Verwendung bei der Behandlung von Krebs, Transplantationen und Autoimmunerkrankungen |
| ZA200809776B (en) * | 2006-05-30 | 2010-03-31 | Genentech Inc | Antibodies and immunoconjugates and uses therefor |
| US8283162B2 (en) * | 2009-03-10 | 2012-10-09 | Abbott Laboratories | Antibodies relating to PIVKAII and uses thereof |
-
2010
- 2010-08-25 US US12/868,338 patent/US20110070227A1/en not_active Abandoned
- 2010-08-26 MX MX2012002907A patent/MX341117B/es active IP Right Grant
- 2010-08-26 AU AU2010294905A patent/AU2010294905B2/en not_active Ceased
- 2010-08-26 BR BR112012006035A patent/BR112012006035A2/pt not_active IP Right Cessation
- 2010-08-26 CN CN2010800412158A patent/CN102574920A/zh active Pending
- 2010-08-26 EP EP10751563.7A patent/EP2478012B1/de active Active
- 2010-08-26 JP JP2012529137A patent/JP5816905B2/ja not_active Expired - Fee Related
- 2010-08-26 KR KR1020127009393A patent/KR20120100914A/ko not_active Application Discontinuation
- 2010-08-26 WO PCT/EP2010/005225 patent/WO2011032633A1/en active Application Filing
- 2010-08-26 EA EA201270433A patent/EA026902B1/ru not_active IP Right Cessation
- 2010-08-26 ES ES10751563.7T patent/ES2608661T3/es active Active
- 2010-08-26 CA CA2774244A patent/CA2774244A1/en not_active Abandoned
- 2010-08-26 IN IN2196DEN2012 patent/IN2012DN02196A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP2478012A1 (de) | 2012-07-25 |
| MX341117B (es) | 2016-08-09 |
| AU2010294905A1 (en) | 2012-04-05 |
| KR20120100914A (ko) | 2012-09-12 |
| US20110070227A1 (en) | 2011-03-24 |
| CA2774244A1 (en) | 2011-03-24 |
| EA201270433A1 (ru) | 2012-10-30 |
| BR112012006035A2 (pt) | 2019-09-24 |
| JP2013505205A (ja) | 2013-02-14 |
| AU2010294905B2 (en) | 2016-09-22 |
| CN102574920A (zh) | 2012-07-11 |
| EA026902B1 (ru) | 2017-05-31 |
| ES2608661T3 (es) | 2017-04-12 |
| JP5816905B2 (ja) | 2015-11-18 |
| EP2478012B1 (de) | 2016-11-09 |
| MX2012002907A (es) | 2012-04-30 |
| WO2011032633A1 (en) | 2011-03-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IN2012DN02196A (de) | ||
| MX2011011925A (es) | Anticuerpos triespecificos o tetraespecificos. | |
| ZA201305123B (en) | Modified antibody with improved half-life | |
| AU333675S (en) | Bottle | |
| AU333674S (en) | Bottle | |
| AP2012006190A0 (en) | Herbicide-tolerant plants. | |
| AP2012006163A0 (en) | Boron-containing small molecules as antiprotozoal agents. | |
| CA143394S (en) | Microwavable bag | |
| WO2012081924A3 (ko) | 자전거 | |
| AP2011005984A0 (en) | Antibodies specific to cadherin-17. | |
| MX350335B (es) | Anticuerpos que enlazan alfa-v beta-8 integrina. | |
| MX349282B (es) | Polisulfuros de organosilicio reticulados. | |
| PL2602805T3 (pl) | Obudowa urządzenia zabezpieczającego przed przepięciami i urządzenie zabezpieczające przed takimi przepięciami | |
| WO2010007168A3 (en) | Treatment of rheumatoid arthritis with mammal beta defensins | |
| WO2010136104A3 (en) | Anti-dandruff agents | |
| MX2012010317A (es) | ß-HIDROXIALQUILAMIDAS, METODO PARA SU PRODUCCION Y SU USO. | |
| TWI561442B (en) | Strap with improved column stiffness | |
| GB201107632D0 (en) | Elastic mount, in particular rubber-metal mount | |
| MX2012012509A (es) | Tapentadol para usarse en el tratamiento del sindrome del intestino irritable. | |
| CA141110S (en) | Bottle | |
| AP2012006243A0 (en) | Saddle type vehicle. | |
| FR2948310B1 (fr) | Etabli du genre table, repliable | |
| AP2010000342S (en) | Tusker bottle. | |
| GB201113152D0 (en) | The express add | |
| PL118767U1 (pl) | Elastyczny wkład, zwłaszcza do spągnicy obudowy górniczej |